2007
DOI: 10.1503/cmaj.070627
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of tobacco dependence: integrating recent progress into practice

Abstract: Smoking is currently responsible for the death of 1 in 10 adults worldwide, or about 5 million deaths each year. Half of the 650 million people who smoke today will eventually be killed by tobacco, 1 and this morbidity and mortality can be mostly avoided if people stop smoking. 2The prevalence of smoking varies greatly around the world. Over 4.5 million people are current smokers in Canada, representing 18% of the population aged 15 years and older.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
58
0
2

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(61 citation statements)
references
References 70 publications
(48 reference statements)
1
58
0
2
Order By: Relevance
“…Nicotine administration is central to tobacco addiction diagnosis (ICD-10) and forms the neuro-biochemical basis of addiction (Foll et al, 2007;IARC, 2008). The behaviour of smokers is controlled by both the positive enforcement -desire to obtain nicotine for its pleasing effect, and the negative enforcement -desire to decrease uncomfortable withdrawal symptoms (IARC, 2008;CDC, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…Nicotine administration is central to tobacco addiction diagnosis (ICD-10) and forms the neuro-biochemical basis of addiction (Foll et al, 2007;IARC, 2008). The behaviour of smokers is controlled by both the positive enforcement -desire to obtain nicotine for its pleasing effect, and the negative enforcement -desire to decrease uncomfortable withdrawal symptoms (IARC, 2008;CDC, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…Similarly to other authors, we also observed a growing rate of female smokers in our sample. 24,25 However, men still account for the highest prevalence rates and are at higher risk for daily tobacco consumption, both among people seeking assistance at health care units and in the general population. [26][27][28] A previous study conducted in Pelotas had already reported similar findings, with prevalence rates of 25.6 and 18.5% for men and women, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…As abordagens farmacológicas e não farmacológicas são efetivas para aumentar a taxa de cessação do tabagismo e a associação das duas formas de tratamento fornece os melhores resultados (34). A disponibilidade de medicação pelos serviços públicos deve ser, portanto, ampliada para aumentar a taxa de abstinência e quebrar esse círculo vicioso.…”
Section: Discussão E Conclusãounclassified